Responses
Other content recommended for you
- Commentary: Placebo run ins have some value
- Design of treatment trials for functional gastrointestinal disorders
- Replication crisis and placebo studies: rebooting the bioethical debate
- More than consent for ethical open-label placebo research
- The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
- Patient attitudes about the clinical use of placebo: qualitative perspectives from a telephone survey
- Are placebo run ins justified?
- Physician perspectives on placebo ethics
- The ethics of the placebo in clinical practice revisited
- The ethics of placebo treatments in clinical practice: a reply to Glackin